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esponsibility of InstAbstract The accessory proteins (3a, 3b, 6, 7a, 7b, 8a, 8b, 9b and ORF14), predicted unknown proteins
(PUPs) encoded by the genes, are considered to be unique to the severe acute respiratory syndrome
coronavirus (SARS-CoV) genome. These proteins play important roles in various biological processes
mediated by interactions with their partners. However, very little is known about the interactions among
these accessory proteins. Here, a EYFP (enhanced yellow ﬂuorescent protein) bimolecular ﬂuorescence
complementation (BiFC) assay was used to detect the interactions among accessory proteins. 33 out of 81
interactions were identiﬁed by BiFC, much more than that identiﬁed by the yeast two-hybrid (Y2H)
system. This is the ﬁrst report describing direct visualization of interactions among accessory proteins of
SARS-CoV. These ﬁndings attest to the general applicability of the BiFC system for the veriﬁcation of
protein-protein interactions.
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The severe acute respiratory syndrome coronavirus (SARS-CoV)
is an enveloped, positive-stranded RNA virus with a very large
genomic size (about 30 kb) and constitutes 14 open reading frames
(ORFs)1,2. The two large overlapping (ORF1a and ORF1b) are
translated to produce polyproteins that are involved in viral RNA
replication and transcription. The downstream ORFs encode the
structural proteins in the following order: spike (S), envelope (E),
membrane (M) and nucleocapsid (N). In addition to these two
groups of proteins, there is another group including accessory
proteins (3a, 3b, 6, 7a, 7b, 8a, 8b, 9b and ORF14) varying in
length from 39 to 274 amino acids (aa) and with no signiﬁcant
sequence homology to proteins in other coronaviruses1,2. The third
group of proteins, named as predicted unknown proteins (PUPs), is
unique to SARS-CoV1,2.
Although the precise functions of these accessory proteins are
still obscure, it seems clear that many of them play important roles
in various biological processes mediated by interactions with their
partners. For example, the 3a protein can interact with structural
proteins like S, M and N proteins, and another accessory protein
7a in SARS-CoV infected cells; the resulting multiple complexes
may be inferred to be important for viral assembly3. Additionally,
the interaction of SARS-CoA protein 6 and another accessory
protein 9b was also conﬁrmed to be present in SARS-CoV infected
cells4. Thus, the identiﬁcation of the occurrence and components
of protein-protein interactions (PPIs) among accessory proteins
provided invaluable insights into the cellular functions of these
proteins. However, very little is known about other interactions
among these accessory proteins5. Given that several accessory
proteins have been shown to exhibit functions in virus-host
interactions during SARS-CoV infection in vivo, it is necessary
to understand the putative interactions among accessory
proteins6,7.
A wide range of methods, including the yeast two-hybrid (Y2H)
analysis8, co-immunoprecipitation (Co-IP) assay9 and bimolecular
ﬂuorescence complementation (BiFC) system10,11, have been
developed for the identiﬁcation and analysis of PPIs in vitro
and in vivo. Each method has its own advantages and limitations.
Co-IP is one of the most commonly used methods for examining
PPIs. This technique often requires the preparation of speciﬁc
antibodies against each of the analyzed proteins, making it an
expensive and time-consuming process12. Also, Co-IP can be
performed using lysates of the cells, which generally prevents the
determination of the exact subcellular localization of the interact-
ing proteins13. Y2H is another means of assessing whether two
single proteins interact. Although used extensively, Y2H suffers
from several drawbacks, such as high occurrence of false-positives
and the requirement that the interacting proteins accumulate in the
cell nucleus8. Among these methods, the ﬂuorescent protein–based
BiFC is an effective and straightforward tool to study PPIs,
enabling direct visualization of the occurrence and subcellular
localization of PPIs with simple equipment. Moreover, this
approach can avoid the possibility of non-physiological protein
interactions caused by cell lysis and mixing the contents of
different cellular compartments. Due to its stronger signal and
direct readout, this assay has become widely accepted over the past
decade10,11,14,15.
In the present investigation, characterization of the interactions
among accessory proteins of SARS-CoV was performed using
BiFC and Y2H. Biochemical evidence revealed the interactions
existed in accessory proteins.2. Materials and methods
2.1. Strains and plasmids
Escherichia coli (E. coli) TG1 was used as a host strain for
subcloning. The strain was grown in Luria–Bertani medium (10 g/L
Bacto–Tryptone, 5 g/L Bacto-yeast extract, 10 g/L NaCl) supple-
mented with ampicillin (100 μg/mL) when required for selection.
BiFC vectors pFA6a-VN-KanMX6 and pFA6a-VC-KanMX6
were kindly supplied by Prof. Won-Ki Huh (Seoul National
University, Republic of Korea)16. The haploid Saccharomyces
cerevisiae (S. cerevisiae) strains AH109 (MATa, his3-200, leu2-3,
112, trp1-901, ura3-52, gal4Δ, gal80Δ, LYS2:: GAL1UAS-GAL1TATA-
HIS3, GAL2UAS-GAL2TATA-ADE2, URA3:: MEL1UAS-MEL1TATA-
lacZ, MEL1)17 and W303-1B (MATa, ura3-1, trp1-1, ade2-1, leu2-
3, 112, his3-11, 15)18 were used to determine PPIs. The GAL4 DNA
binding domain (BD) vector pGBKT7 and pGBT9, and the activation
domain (AD) vector pGADT7 were from Clontech Laboratories, Inc.
(Mountain View, USA) and were used throughout. The yeast
expression vector pYeDP60 was kindly provided by Prof. Werck-
Reichhart (France). pYeDP60 is a 2 mm plasmid with GAL10-CYC1
promoter, URA3 and ADE2 marker19,20. All yeast strains were grown
either in the non-selective YPD medium (10 g/L yeast extract, 20 g/L
bactopeptone and 20 g/L glucose) or in the selective SD medium
(0.7% yeast nitrogen base without amino acids, 0.1% casamino acids
and 2% glucose) with appropriate amino acids dropped out at 30 1C.
The detailed plasmids and strains used in the work are listed in Table
S1 in Supporting information.
2.2. Enzymes and chemicals
In-Fusions HD Cloning Kit, Restriction enzymes and X-α-gal
were purchased from Takara Shuzo Co., Ltd. (Kyoto, Japan).
KOD Plus Taq DNA polymerase was purchased from Toyobo Co.,
Ltd. (Osaka, Japan). All other ﬁne chemicals were of analytical
grade and commercial available.
2.3. Cloning of SARS-CoV accessory genes
ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8a, ORF8b, ORF9b
and ORF14 genes were chemically synthesized respectively,
according to the genome sequence of SARS-CoV Tor2 isolate
(GenBank accession number AY274119.3)2. After the sequence
conﬁrmation, the genes were subcloned into the vector pMD™18-T
to acquire nine vectors named pMD3a, pMD3b, pMD6, pMD7a,
pMD7b, pMD8a, pMD8b, pMD9b and pMDORF14, which were
used as template to construct Y2H expression vectors and BiFC
plasmids by the In-Fusion method.
2.4. Plasmids construction for Y2H assay
Speciﬁc PCR primers (Table S2 in Supporting information) were
designed according to the sequences of SARS-CoV accessory genes
and used to amplify each accessory gene by using of KOD Plus Taq
DNA polymerase. The PCR products were ligated into the NdeI and
EcoRI double digested vectors pGADT7 and pGBKT7, respec-
tively, using the In-Fusion method. The resulting constructs pGAD-
APs and pGBK-APs (APs refer to ORF3a, ORF3b, ORF6, ORF7a,
ORF7b, ORF8a, ORF8b, ORF9b and ORF14 genes) (Figs. S1 and
S2 in Supporting information) containing SARS-CoV accessory
genes were veriﬁed by custom sequencing.
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The resulting yeast two-hybrid vectors pGAD-APs and pGBK-APs
were then co-transformed into S. cerevisiae AH109 by use of the
LiAc transformation method21. The transformed yeasts were then
grown on SD-Leu-Trp medium (leucine and tryptophan are omitted
from the formulation) for 3–7 days at 30 1C. Colonies with 2–3 mm
in diameter were transferred to solid SD-Ade-His-Leu-Trp medium
and grown for 3–5 days at 30 1C.
For testing APs interactions, combinations of APs-bait and
APs-prey constructs co-expressed in yeast were subjected to
α- and β-galactosidase assay according to the manufacturer's
instructions (Yeast Protocols Handbook, PT3024-1, Clontech
Laboratories, Inc.). Each experiment was separately repeated in
triplicate.
2.6. Construction of BiFC plasmid vectors
pFA6a-pGAL10CYC1-VN-KanMX6 and pFA6a-GAL10CYC1-
VC-KanMX6: the DNA sequence coding for the GAL10-CYC1
promoter was ampliﬁed by polymerase chain reaction (PCR) from
pYeDP60 using primer pair FGAL10CYC1 and RGAL10CYC1
(Table S2 in Supporting information). The ampliﬁed 800-bp PCR
fragment was directionally cloned into the linearized vectors
pFA6a-VN-KanMX6 and pFA6a-VC-KanMX6 with restriction
digestion of SalI, respectively. The resulting recombinant vectors
pFA6a-GAL10CYC1-VN-KanMX6 and pFA6a-GAL10CYC1-
VC-KanMX6 were veriﬁed by sequencing.
pGAL10CYC1-VN and pGAL10CYC1-VC: the fusion frag-
ment of GAL10-CYC1 promoter and ORF encoding N-terminus
(aa 1173, VN173) or C-terminus (aa 155238, VC155) of
Venus, a variant of yellow ﬂuorescent protein, were ampl-
iﬁed by PCR, using primers FGBT9GAL10CYC1 and RGBT-
9GAL10CYC 1 (VN173) or FGADT7GAL10CYC1 and RGAD-
T7GAL10CYC1 (VC155). The resulting PCR products of
GAL10CYC-VN173 and GAL10CYC-VC155 were inserted into
pGBT9 linearized by SphI and pGADT7 double digested by SphI/
NcoI to construct the yeast BiFC expression vector pGAL-
10CYC1-VN and pGAL10CYC1-VC, respectively.
pAPs-VN and pAPs-VC: the encoding sequences of SARS-CoV
accessory proteins were ampliﬁed by individual primer and
inserted into the SalI-digested vectors pGAL10CYC1-VN and
pGAL10CYC1-VC to produce BiFC vectors pAPs-VN and pAPs-
VC (Figs. S3 and S4 in Supporting information).
2.7. Microscopy and image analysis
The BiFC plasmid pAPs-VN and pAPs-VC were co-introduced
into the S.cerevisiae strain W303-1B by the LiOAc/SS carrier
DNA/PEG method according to Gietz et al.21 to give the yeast
strain W303B[pAPs-VNþpAPs-VC]. Transformants were selected
using a SD-Leu-Trp drop-out medium (SD medium without
leucine and tryptophan). Veriﬁcation of positive clones was done
by extraction of yeast plasmids and further colony PCR. Yeast
cultures were initially grown in 10 mL SD-Leu-Trp liquid medium
at 30 1C to an OD600 of 2–3. The cells of 1 mL were centrifuged
and washed three times by ddH2O. The resultant cell was
resuspended in 50 mL induction YPD medium containing 2%
galactose and grown at 30 1C for 16–24 h. 1 mL of S. cerevisiae
cells was harvested by centrifugation at 13,000 rpm for 5 min. The
cell pellets were resuspended in concanavalin A (1 mg/mL) buffer.100 μL cells were removed and plated on the center of microscope
slides covered with coverslips. Microscopic analysis was per-
formed by a Nikon Eclipse 80i epiﬂuorescence microscope
equipped with YFP-, RFP- and UV-speciﬁc ﬁlters, a 40 /0.75
objective and a CCD camera applying differential interference
contrast. The images were acquired using NIS-Elements F soft-
ware and processed using Adobe Photoshop 7.0.1. YFP signal was
detected between 515 and 565 nm after excitation by 450–
499 nm laser.3. Results
3.1. Detection of SARS-CoV accessory protein interactions by
yeast two-hybrid assay
AH109 contains distinct ADE2, HIS3, lacZ and MEL1 reporter
constructs that are under the control of distinct GAL4-responsive
promoters and only expressed in the presence of GAL4-based
protein interactions. To reduce false positive results, all of these
reporter genes were used as part of the conﬁrmation step of Y2H
assay. SD-Ade-His-Leu-Trp medium was ﬁrst used to examine the
interaction. Cells harboring pGAD-APs and pGBK-APs are able to
grow SD-Leu-Trp dropout medium because the plasmids encode
tryptophan and leucine biosynthesis genes, respectively. When two
proteins encoded by accessory genes of SARS-CoV interact,
GAL4-responsive HIS3 and ADE2 expression is activated, allowing
these cells to grow on SD-Ade-His-Leu-Trp minimal medium. The
strains AH109[pGBKORF9bþpGADORF9b], AH109[pGBKOR-
F8aþpGADORF9b] and AH109[pGBKORF14þpGADORF14]
survived from SD-Ade-His-Leu-Trp medium after 3–5 d at
30 1C, implying the interactions of 8a-9b, 9b-9b and ORF14-
ORF14 (Table 1). Yeast colonies turned blue when the strains
mentioned above were plated on SD-Ade-His-Leu-Trp medium for
3–5 d at 30 1C in the presence of the chromagenic substrate X-α-
Gal (an indicator of LacZ expression regulated by a GAL4-
responsive promoter). This result further supported by the 8a-9b,
9b-9b and ORF14-ORF14 interactions.
The LacZ gene encodes β-galactosidase whereas MEL-1 encodes
α-galactosidase, an enzyme occurring naturally in many yeast
strains. As a result of two-hybrid interactions, both β-galactosidase
and α-galactosidase are expressed and α-galactosidase is secreted by
the yeast cells. The quantitative assays of β-galactosidase and
α-galactosidase were performed and the detailed results are listed
in Table 2.
3.2. Detection of SARS-CoV accessory protein interactions by
BiFC
In order to validate the interactions between SARS-CoV accessory
proteins, we ﬁrst constructed pFA6a-based plasmids, pAPs-VN
and pAPs-VC (APs refer to SARS-CoV accessory genes) used
for BiFC in S.cerevisiae. Fusion genes of the GAL10-CYC1
promoter and ORFs encoding the N- or C-terminal domains of
the engineered YFP protein Venus were ampliﬁed by PCR and
cloned separately into plasmids pGBT9 and pGADT7 to obtain
BiFC plasmid pGAL10CYC1-VN and pGAL10CYC1-VC. The
SARS-CoV accessory genes were inserted into the polylinker
between the GAL10-CYC1 promoter and the sequence encoding
N- or C-terminal domains of Venus. The BiFC plasmids carrying
accessory genes were co-transformed into the single yeast cell to
identify interactions. Figs. S3 and S4 in Supporting information
Table 2 α-Galactosidase and β-galactosidase assay of protein interactions of 9b-9b, 8a-9b and ORF14-ORF14 (n¼3).
Strain α-Galactosidase β-Galactosidase
AH109[pGBKORF9bþpGADORF9b] 2.5270.18 8.8071.99
AH109[pGBKORF8aþpGADORF9b] 1.1770.03 6.9172.03
AH109[pGBKORF14þpGADORF14] 1.8470.43 6.0371.31
Table 1 Protein interactions identiﬁed by Y2H.
pGBK3a pGBK3b pGBK6 pGBK7a pGBK7b pGBK8a pGBK8b pGBK9b pGBK ORF14
pGAD3a         
pGAD3b         
pGAD6         
pGAD7a         
pGAD7b         
pGAD8a         
pGAD8b         
pGAD9b      þþ  þþ 
pGAD ORF14         þþ
“þþ” represents strong interaction; “” represents no interaction.
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pAPs-VC.
Following plasmid construction, pAPs-VN and pAPs-VC were
co-transformed into yeast cell W303-1B in an effort to generate the
81 possible VN173-VC155 combinations for BiFC analysis.
Galactose was added into the engineered yeast to induce the
expression of SARS-CoV accessory protein labeled with Venus-
VN173 and Venus-VC155, respectively. To visualize BiFC signals,
exponentially-growing cells were examined under the ﬂuorescence
microscope. As illustrated in Fig. 1, strong ﬂuorescence could be
detected within 24 protein partners, including pVN3a-pVC3a and
pVN3a-pVC7a (Table 3). The ﬂuorescence was localized to discrete
regions in the cell. Moreover, weak ﬂuorescence signal was
observed in the following 9 cells containing protein pairs:
[pVN3b-pVC3a], [pVN3b-pVC7b], [pVN3b-pVC8a], [pVN6-
pVC8a], [pVN7b-pVC8a], [pVN7b-pVCORF14], [pVN9b-pVC7a],
[pVN9b-pVC7b] and [pVNORF14-pVC6] (Table 3). No BiFC
signals were detected in the remaining 48 cells, suggesting that
the N- and C-terminal fragments of Venus are insufﬁciently close to
allow YFP complex formation (Table 3). Protein 8b did not interact
with any other accessory protein. Results also found 5 self-
interacting SARS-CoV accessory proteins 3a, 6, 7a, 7b and 9b,
indicating that these proteins can form dimer or multimers in vivo.
Eight pairs of interactions were detected in both directions that are
3a-6, 3a-7a, 3a-7b, 6-7a, 6-7b, 6-8a, 7a-7b and 7b-8a.4. Discussion
Although the SARS epidemic has not reoccurred since the ﬁrst
outbreak in 2003, substantial research has continued in an effort to
increase the understanding of SARS-CoV, and to search for
effective anti-SARS-CoV therapeutic agents.
The group-speciﬁc accessory proteins of SARS-CoV have been
shown to be dispensable for viral replication, but they can
contribute to viral stability and pathogenesis in the natural hosts.
Therefore, investigations on the interactions between accessoryproteins will facilitate an understanding of the role of these genes
in the pathogenesis and propagation of SARS-CoV.
In the present investigation, interactions of SARS-CoV acces-
sory proteins were detected by the Y2H method and BiFC assay,
respectively. The Y2H assay is a widely used method to study
PPIs, based on the fact that many eukaryotic transcription factors,
such as the yeast enhancer GAL4, are composed of two function-
ally distinct domains that mediate transcriptional activation
domain (AD) and DNA binding domain (BD) respectively. As
illustrated in Table 3, of 81 interactions detected by Y2H, only 3
interactions were indicated to be positive, viz., self-interactions of
9b and ORF14, and interaction of 8a-9b in one direction. Self-
interactions were observed with 9b and ORF14, indicating the
formation of dimeric or multimeric complexes in the nucleus,
similar to the ﬁndings of von Brunn et al.5. PPIs of 8a-9b occurred
in one direction only when 8a and 9b proteins were separately
fused to pGBKT7 and pGADT7, but the opposite was reported by
von Brunn et al.5. Moreover, the number of protein interactions is
inconsistent with the study by von Brunn et al.5, who identiﬁed 11
interactions among accessory proteins of SARS-CoV. This dis-
crepancy resulted from the selection method used. The interactions
were identiﬁed mainly using the selective plates, which can result
in false positive results. Moreover, of 13 interactions detected by
Y2H, only 4 were corroborated by Co-IP, which further implied
the detection of false positive interactions by Y2H. In the present
investigation, more comprehensive selection methods were applied
to characterize the interactions. Besides selective plates, colony
PCR, quantitative β-galactosidase and α-galactosidase assays were
used to validate the interaction among accessory proteins, which
improve the reliability of Y2H.
Although Y2H results are major contributor to PPIs databases,
these methods present several limitations. For example, the
original Y2H cannot detect interactions between proteins targeting
compartments other than the nucleus. Therefore, in order to avoid
missing interactions in other compartments, BiFC was used to
further verify the interacting partners after Y2H identiﬁcation in
the present investigation.
Figure 1 Visualization of interactions of pVN3a-pVC3a (top panel) and pVN3a-pVC7a (bottom panel) using a split-EYFP based bimolecular
ﬂuorescence complementation assay. The rest of 31 interactions among accessory proteins were also visualized under the same conditions (data not
shown). BiFC, bimolecular ﬂuorescence complementation assay images; DIC, differential interference contrast images; Merged, merged images of
DIC and BiFC.
Table 3 Protein interactions identiﬁed by BiFC.
pVC3a pVC3b pVC6 pVC7a pVC7b pVC8a pVC8b pVC9b pVCORF14
pVN3a þþ  þþ þþ þþ    
pVN3b þ    þ þ   
pVN6 þþ  þþ þþ þþ þ   
pVN7a þþ  þþ þþ þþ    
pVN7b þþ  þþ þþ þþ þ   þ
pVN8a þþ  þþ þþ þþ    
pVN8b         
pVN9b þþ  þþ þ þ   þþ 
pVNORF14 þþ  þ      
“þþ” represents strong interaction; “þ” represents weak interaction; “” represents no interaction.
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the association of two fragments of a ﬂuorescent protein when they are
brought together by an interaction between proteins fused to the
fragments14,22,23. In principle, the BiFC assay can be used to detect
interactions in any subcellular compartment in any aerobically growing
organism or cell that can be genetically modiﬁed to express the fusion
proteins24. BiFC, hence, can detect interactions not observed with
Y2H. In the present study, 33 out of 81 interactions were visualized by
BiFC. Only one Y2H interaction, namely self-interaction of 9b, was
conﬁrmed by BiFC. The self-interaction of 9b was also reported by
von Brunn et al.5. The ﬁndings of the self-interaction of 9b identiﬁed
by BiFC, coupled with the absence of nuclear localization signal
(NLS) of 9b imply that the self-interactions also occur in the extra-
nuclear domain. The conclusion that the 9b protein is retained in both
the intra- and extra-nuclear domains is consistent with the paper by
Sharma et al.25. In this report, the authors demonstrated that 9b protein
can enter the nucleus by passive transport, though 9b was known to
localize in the extra-nuclear region25.The other two Y2H interactions, the self-interaction of ORF14
and interaction between 8a-9b, cannot be seen by BiFC. Additional
comprehensive studies are needed to explain this discrepancy.5. Conclusions
The present report has used multiple, overlapping, comprehensive
methods to conﬁrm the existence of well-characterized accessory
protein interactions, but also to discover new interactions among
these proteins. These interactions provide important clues for a
more comprehensive understanding of the SARS-CoV accessory
proteins.
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